Clínic Barcelona
Clínic Barcelona
August 27 2013
Dr. Josep Dalmau is an ICREA investigator leading the IDIBAPS Autoimmunity against synaptic antigens Group. His international impact is reflected in1
Early treatment of asymptomatic high-risk smoldering myeloma could significantly improve the course of disease, slowing its progression and significa1